Batch-matched versus generic COA: why the lot number has to match the vial

The check takes ten seconds and deserves to come first: read the batch string off the label on the vial, then find it character for character inside the Certificate of Analysis. If it matches, the document describes the material in your hand. If it does not — or if the field is blank, says "N/A", or vaguely refers you back to the label — the document describes some other material, and every number in it belongs to that material rather than to yours.

A generic COA is exactly that: a document that travels with the product code instead of with the batch. It is not necessarily forged. Very often it is a genuine test report, from a real laboratory, covering a batch that sold out months ago and that keeps being posted alongside every new shipment. The inaccuracy is not in the data. It is in the silent assumption that the next batch inherits the previous batch's results.

What a batch is, and what its number promises

The regulatory vocabulary is unusually clean here. A batch is a specific quantity of material produced in a process or series of processes so that it is expected to be homogeneous within specified limits. A batch number is defined as a unique combination of numbers, letters and/or symbols that identifies a batch and from which the production and distribution history can be determined ^[1]. The second half of that definition is the load-bearing half: a number that leads to no record is not a batch number, it is packaging decoration.

"Batch" and "lot" are used as synonyms in the same vocabulary, and Greek renders both as «παρτίδα» ^[1]. In practice that means a vial carrying two different strings, one marked Batch and one marked Lot, needs an explanation from the supplier: either these are a synthesis batch and a fill batch, in which case both should appear somewhere in the documentation, or one of the two is a leftover from a template.

The same good-manufacturing-practice guide also sets out what normal practice looks like for the certificate itself: authentic certificates of analysis are issued for each batch, they carry the name of the material and, where relevant, its grade, the batch number and the release date, and they list every test performed together with the acceptance limits and the numerical results obtained ^[1]. The key phrase is not the list of fields. It is "for each batch".

Why one batch's result does not carry over to the next

The common objection is reasonable: if the synthesis is the same and the purification protocol did not change, why would batches not resemble each other? They do resemble each other. They are not identical. Solid-phase synthesis generates a predictable set of impurity classes — deletion and insertion sequences, truncated sequences, incomplete deprotection, epimerisation, oxidation and deamidation, dimers and aggregates ^[5], each with its own chemistry and its own analytical signature. What is not predictable is the proportion of each in any given run.

That is why regulatory guidance on synthetic peptides treats the impurity profile as something documented and monitored per batch rather than as a fixed property of the product ^[6]. And it is why small differences matter in laboratory work: in one published incident, synthetic peptide libraries from two independent commercial suppliers were found to contain foreign peptides at roughly 1% by weight, enough to produce false positives in immunological assays ^[10]. Those were in vitro findings on specific preparations, not a clinical study and not a survey of the market.

The chain does not stop at synthesis either. Purification, counter-ion exchange, lyophilisation and vial filling are all performed batch by batch, each with its own residual moisture, its own residual solvents and its own microbiological history. Even the retest date is a property of the batch rather than of the catalogue number: it is calculated from the analysis date of that particular batch.

Generic, "typical" and borrowed: three ways a certificate fails to match

The distinction already exists in written standard form, in the world of reference materials. ISO Guide 31:2015 separates the reference material certificate, which carries values assigned to a specific batch, from the product information sheet, which carries indicative values, and it sets out separately the minimum content of the label on the container so that the two can be matched to each other ^[9]. A document headed "typical analysis" or "representative COA" is, in those terms, an information sheet dressed as a certificate.

In practice the failure shows up in a handful of repeating forms. None of them requires chemistry to spot — only two documents read side by side:

• The batch field is empty, reads "N/A", or points back at the label instead of stating a value.
• The number on the COA exists, but appears nowhere on the vial or on the secondary packaging.
• The vial carries two different strings with no explanation of what each one represents.
• The analysis date precedes the manufacturing date, or is identical across every product in the catalogue.
• The same chromatogram, with identical retention times and identical baseline noise, appears for two different batches.
• A retest date is given with no connection at all to the analysis date of that specific batch.
• The document names no laboratory and carries no report number — so there is no record for anyone to return to.

What the standard says about test reports

Matching is not a commercial suggestion; it is a requirement written into a standard. ISO/IEC 17025:2017 lists in clause 7.8.2.1 what a test report must contain, and two of those items address precisely this question: a description and unambiguous identification of the item that was tested, and a statement to the effect that the results relate only to the items tested ^[2]. The second of those is, quite literally, the batch rule expressed as an obligation on the laboratory.

In Greece the standard is published as ΕΛΟΤ EN ISO/IEC 17025:2017, and accreditation of testing laboratories is granted by the national accreditation body, Ε.ΣΥ.Δ. ^[8]. Two points change how a COA reads. Accreditation is granted per method and per scope, not to a company as a whole, and every accredited laboratory has a certificate number with a published scope. An accreditation logo without a number is therefore not checkable, while one with a number is — and checking it needs no sample and no laboratory of your own.

Why the batch number is not a legal requirement on this label

This is the root of the problem, and it is worth stating rather than implying. For a medicinal product, European law requires the manufacturer's batch number on the outer packaging, among the mandatory particulars of Article 54, and keeps it even on very small immediate packagings, where the list of particulars shrinks to the bare minimum ^[3]. The batch number survives where almost everything else is cut, because it is the basis of recall.

For a chemical supplied under the CLP Regulation the picture is different. Article 17 lists the label elements: the name, address and telephone number of the supplier, the nominal quantity where the product is made available to the general public, product identifiers, hazard pictograms, a signal word, hazard statements, precautionary statements, and a section for supplemental information ^[4]. The batch number is not among them.

Research-use-only material is not a medicinal product, and the designation carries a narrower meaning than it is usually read as carrying: it holds no marketing authorisation from the Greek National Organisation for Medicines (ΕΟΦ) or from the European Medicines Agency, and it does not fall under Article 54 ^[3]. The practical consequence runs exactly opposite to what most buyers assume. A batch number on a research vial is not there because anyone compels it; it is there because the supplier keeps a traceability system. That is precisely why its presence, its consistency and its correspondence to the paperwork say something real about the supplier.

When the certificate does not come from the manufacturer

The usual route in the research peptide market involves at least one intermediary: a manufacturer, a reseller or repacker, and a final supplier. Good manufacturing practice addresses this case explicitly. Where a new certificate is issued by or on behalf of repackers, agents or brokers, it should name the laboratory that performed the analysis, reference the name and address of the original manufacturer, and reference the original batch certificate, a copy of which should be attached ^[1].

A reseller's COA with no reference to the original breaks the chain at exactly one point: where the material changed hands. And the converse holds too, which is said far less often. A flawless manufacturer's certificate that reaches you through two intermediaries does not prove that your vial came from that batch — it proves that the batch existed and was measured. The only bridge between the document and the material is the correspondence of the label.

The receiving check, in five lines

1. Read the batch string off the vial's own label, not off the packing slip or the catalogue page.
2. Find it verbatim inside the COA, character by character. Hyphens, leading zeros and capitals all count.
3. Confirm the document names a laboratory and carries a report number, a date and a signatory.
4. Check the dates are consistent: analysis follows manufacture, retest follows analysis.
5. Record anything that does not match in the receiving log, dated, before the vial is opened — once it is open there is no way to show what condition it arrived in.

Where the evidence is weak

There is no published, independent study of how often COAs in the research peptide market actually correspond to the vial they accompany. Anyone quoting a percentage for this is estimating. The empirical base that does exist concerns prescription products sold illegally online — where independent testing of what such vials actually contain has at least been attempted — and is indicative only as to the kind of failures involved: in a 2024 market-surveillance study, the vials that were successfully delivered were assessed against a 22-item visual inspection checklist adapted from the International Pharmaceutical Federation and failed the majority of it, with deficiencies that included manufacturer details and dates on the label, while measured purity fell dramatically short of the "99%" the packaging claimed ^[7].

The second limit is more uncomfortable. A batch number is not independently verifiable by the recipient. It belongs to the producer's record system, and confirming it means access to that record ^[1]. What can be checked from your side of the bench is internal consistency — label, certificate, packing slip, dates, laboratory identity. That is a filter, not a guarantee: it screens out carelessness, it does not screen out intent.

The third limit is institutional. The standards referenced here were written for active pharmaceutical ingredients and for certified reference materials ^[1][5][9]. They do not apply to research-use-only material, and citing them is not a claim of compliance. They serve as vocabulary and as a comparison bar: they show what complete batch documentation looks like, so that it becomes visible how far a given document falls short of it.